Eurepa-v 1/0.2tablet

EUREPA-V 1/0.2 TABLET

EUREPA-V 1/0.2 Tablet, manufactured by TORRENT PHARMACEUTICALS LTD, is a combination medication used in the management of Type 2 Diabetes Mellitus.

• Composition:

  • Active Ingredients: Repaglinide (1 mg) and Voglibose (0.2 mg).

• Uses: EUREPA-V 1/0.2 Tablet is prescribed for the treatment of Type 2 Diabetes Mellitus. It helps to control high blood sugar levels, particularly after meals, when diet, exercise, and single anti-diabetic medications are insufficient. This medication aids in preventing serious long-term complications associated with diabetes, such as kidney damage, vision problems, nerve issues, and cardiovascular diseases.

• Dosage and Administration: The typical dosage is one tablet taken before main meals, usually 15 to 30 minutes prior. The tablet should be swallowed whole with a glass of water and not crushed or chewed. Your doctor will determine the exact dose and duration of treatment. It is crucial not to stop taking the medicine without consulting your doctor. If a dose is missed, do not take a double dose; instead, wait until your next meal and take it as usual.

• Side Effects: Common side effects may include hypoglycemia (low blood sugar), bloating or diarrhea, headache, fatigue, dizziness, stomach pain, skin rash, fever, muscle pain, tenderness, nausea, flatulence, heartburn, and joint pain. Symptoms of overdose can lead to severe hypoglycemia, characterized by dizziness, sweating, tremor, headache, loss of consciousness, seizure, or coma.

• Precautions: Exercise caution if you have kidney or liver problems; the medicine is not recommended for severe kidney or liver disease, and dosage adjustments may be necessary. Pregnant or breastfeeding women should consult their doctor before use, as it may be unsafe during these periods. Avoid alcohol consumption as it can increase the risk of hypoglycemia. Always carry a source of sugar to manage potential low blood sugar episodes. Inform your doctor about all other medications you are taking to prevent potential drug interactions.

• Storage: Store EUREPA-V 1/0.2 Tablet below 30°C, in a cool, dry place, protected from light and moisture, and in its original packaging. Keep out of the reach of children.

Here are the frequently asked questions about EUREPA-V 1/0.2TABLET:

What is EUREPA-V 1/0.2 TABLET used for?

EUREPA-V 1/0.2 TABLET is used to treat Type 2 Diabetes Mellitus in adults. It is typically prescribed when diet, exercise, and other single anti-diabetic medications are not sufficient to control high blood sugar levels, especially after meals. It helps manage blood sugar spikes and reduces the risk of long-term diabetes complications like kidney damage, eye problems, and nerve issues.

How does EUREPA-V 1/0.2 TABLET work?

EUREPA-V 1/0.2 TABLET contains two active ingredients: Repaglinide and Voglibose. Repaglinide works by stimulating the pancreas to release more insulin quickly after meals, which helps lower blood sugar. Voglibose is an alpha-glucosidase inhibitor that slows down the digestion and absorption of carbohydrates in the intestine, thereby preventing sudden rises in blood glucose levels after eating.

What is the usual dosage for EUREPA-V 1/0.2 TABLET?

The dosage of EUREPA-V 1/0.2 TABLET is determined by your doctor based on your individual condition and response to treatment. It is usually taken orally, one tablet with or just before each main meal (typically 15 to 30 minutes before). It's crucial to follow your doctor's instructions precisely and not to alter the dose or stop the medication without consulting them.

What are the possible side effects of EUREPA-V 1/0.2 TABLET?

Common side effects can include hypoglycemia (low blood sugar), abdominal pain, diarrhea, nausea, flatulence (gas), headache, fatigue, dizziness, skin rash, fever, and muscle pain. Most of these side effects are temporary and resolve over time. However, if any of these symptoms persist or worsen, you should consult your doctor.

Is EUREPA-V 1/0.2 TABLET safe during pregnancy or breastfeeding?

EUREPA-V 1/0.2 TABLET is generally considered unsafe for use during pregnancy as it may harm the unborn baby. It is also not recommended during breastfeeding, as it can be harmful to the newborn. If you are pregnant, planning a pregnancy, or breastfeeding, you must inform your doctor, who may suggest alternative treatments.

Can EUREPA-V 1/0.2 TABLET be taken with other medications?

EUREPA-V 1/0.2 TABLET can interact with several other medications. It's important to inform your doctor about all medicines, including prescribed, over-the-counter, herbal, and dietary supplements you are taking. Specific interactions include an increased risk of hypoglycemia when taken with other anti-diabetic medicines (like insulin or sulfonylureas), and it should be avoided with cholesterol-lowering medicines like gemfibrozil. Caution is also advised with certain antibiotics (e.g., clarithromycin, trimethoprim), anti-tuberculosis medicines (e.g., rifampicin), NSAIDs (e.g., ibuprofen, aspirin), and immunosuppressants (e.g., ciclosporin).

What precautions should be taken while using EUREPA-V 1/0.2 TABLET?

Do not use EUREPA-V 1/0.2 TABLET if you have Type 1 diabetes, severe liver disorder, metabolic acidosis, or certain gastrointestinal disorders. Use with caution if you have mild to moderate liver or kidney impairment, as dosage adjustments may be necessary. Alcohol consumption should be limited or avoided as it can increase the risk of hypoglycemia. Regular monitoring of blood sugar levels is essential, and you should always carry a source of sugar (like juice or chocolate) to manage symptoms of low blood sugar.

What happens if a dose of EUREPA-V 1/0.2 TABLET is missed?

If you miss a dose of EUREPA-V 1/0.2 TABLET, take it as soon as you remember. However, if it's almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to compensate for the missed one, as this can increase the risk of side effects.

How should EUREPA-V 1/0.2 TABLET be stored?

EUREPA-V 1/0.2 TABLET should be stored at room temperature, typically below 30°C (or between 20-25°C), in a dry place. Keep it protected from moisture and direct sunlight, and always keep it out of the sight and reach of children.